SCHEMBL29206385

SCHEMBL29206385

CN(C)CCc1c[nH]c2c(F)cc(O)cc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 7/20 0.57
HTR2A P28223 5/20 0.57
HTR2C P28335 5/20 0.57
SLC6A4 P31645 2/20 0.57
HTR2B P41595 4/20 0.54
MPO P05164 1/20 0.50
HTR6 P50406 2/20 0.45
GPR84 Q9NQS5 1/20 0.44
HTR1D P28221 2/20 0.43
HTR1B P28222 2/20 0.43
HTR3E A5X5Y0 1/20 0.43
HTR3B O95264 1/20 0.43
HTR1E P28566 1/20 0.43
HTR1F P30939 1/20 0.43
HTR7 P34969 1/20 0.43
HTR3A P46098 1/20 0.43
HTR5A P47898 1/20 0.43
HTR4 Q13639 1/20 0.43
HTR3D Q70Z44 1/20 0.43
HTR3C Q8WXA8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29206396 0.89 HTR2A (0.54) HTR1AHTR2AHTR2CSLC6A4HTR2B
SCHEMBL30877260 0.87 HTR1D (0.47) HTR1AHTR2AHTR2CSLC6A4HTR2B
SCHEMBL29206402 0.87 HTR1D (0.47) HTR1AHTR2AHTR2CSLC6A4HTR2B
SCHEMBL29206462 0.86 HTR2A (0.43) HTR1AHTR2AHTR2CSLC6A4HTR2B
SCHEMBL30877245 0.86 HTR2A (0.43) HTR1AHTR2AHTR2CSLC6A4HTR2B
SCHEMBL29206430 0.86 HTR1D (0.59) HTR1AHTR2AHTR2CSLC6A4MPO
SCHEMBL29206492 0.85 HTR2A (0.42) HTR1AHTR2AHTR2CSLC6A4HTR2B
SCHEMBL30877232 0.85 HTR2A (0.42) HTR1AHTR2AHTR2CSLC6A4HTR2B
SCHEMBL30483767 0.85 GPR84 (0.63) HTR1AHTR2AHTR2CSLC6A4HTR2B
SCHEMBL25747528 0.85 GPR84 (0.63) HTR1AHTR2AHTR2CSLC6A4HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117957211-A Fluorinated tryptamine compounds, analogs thereof, and methods of use thereof 圣约瑟夫大学 2024-04-30 CN claimed
US-20240286998-A1 FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME SAINT JOSEPH'S UNIVERSITY 2024-08-29 US disclosed
CN-117957211-A Fluorinated tryptamine compounds, analogs thereof, and methods of use thereof 圣约瑟夫大学 2024-04-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240286998-A1 FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME TPH2, TPH1, HNMT HTR1A 9/4885HTR2A 4/4885HTR2C 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.